Mraz, Amerine & Associates, Inc. Sanofi Transaction History

Mraz, Amerine & Associates, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$45.3 - $51.62 $185,730 - $211,642	-4,100 Closed	0 $0
Q2 2020 Jul 29, 2020	SELL	$42.91 - $52.5 $42,910 - $52,500	-1,000 Reduced 19.61%	4,100 $209,000
Q1 2019 May 08, 2019	SELL	$40.83 - $45.43 $16,332 - $18,172	-400 Reduced 7.27%	5,100 $226,000
Q4 2018 Feb 11, 2019	SELL	$41.48 - $45.59 $8,296 - $9,118	-200 Reduced 3.51%	5,500 $239,000
Q3 2018 Nov 14, 2018	SELL	$40.0 - $44.84 $8,840 - $9,909	-221 Reduced 3.73%	5,700 $255,000
Q2 2018 Aug 14, 2018	BUY	$37.63 - $41.22 $222,807 - $244,063	5,921 New	5,921 $237,000
Q4 2017 Feb 05, 2018	SELL	$42.86 - $50.61 $175,511 - $207,247	-4,095 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$47.04 - $50.34 $192,628 - $206,142	4,095	4,095 $204,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Mraz, Amerine & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Mraz, Amerine & Associates, Inc. with notifications on news.